ADME Toxicology Testing Market

ADME Toxicology Testing Market Size (2020 to 2025)

The size of the global ADME toxicology testing market is estimated to grow a CAGR of 12.2% from 2020 to 2025.

ADME toxicology testing performance is directly dependable on the toxicity of the drug and having lower side effects with high positive results in reducing the health disorder. With increasing concern over animal rights, in vitro technology is highly recommended in almost every laboratory to have better benefits. The prediction technology is all good to have the highest growth rate in the foreseen years with varied advantages. North America is positioned first in holding the most significant shares of the global ADME toxicology testing market.

The rapid increase in several diseases and the demand for the discovery of new medicines to lower the risk of death and other effects are primarily accelerating the market's growth. The support from the government in investments to launch various new products is impacting the positive development of the global ADME toxicology testing market.

However, fluctuations in the availability of the raw materials are hampering the growth of the market. The increasing prices of pharmaceutical products and violations in following rules and regulations by agencies are challenging factors in the global ADME toxicology testing market.

The adoption of new techniques in finding a way to launch different products in significantly less time and lower side effects provides growth opportunities for the market. The reduced cost of affordable medicines by ordinary people due to ADME toxicology testing is lavishing the chance for the market to grow extensively. 

REPORT COVERAGE:

This research report on the global ADME toxicology testing market has been segmented and sub-segmented based on the method, technology, application, end-user, and region.

ADME Toxicology Testing Market – By Method:

• Cellular Assay
• Biochemical Assay
• In Silica
• Ex-vivo

The Cellular Assays has been leading to have a considerable share value in the global ADME toxicology testing market based on the product. Factors such as accurate, highly detailed methods are the reason for segment growth. These assays don’t eliminate clinical experiments, but they make human research successful with less risky action to achieve better results.

ADME Toxicology Testing Market – By Technology:

• Cell Culture
• High Throughput
• Molecular Imaging
• OMICS Technology

Based on technology, Cell Culture technology to have a dominant share in the global ADME toxicology testing market. From 2D cell culture to 3D cell culture, the transformation completed where 3D shows the visual result and the skill to test in lower volumes.

ADME Toxicology Testing Market – By Application:

• Systemic Toxicity
• Renal Toxicity
• Hepatotoxicity
• Neurotoxicity
• Others

Based on the application, Systemic toxicity held a prominent market share. It continued its power and influence throughout the period due to the upward or forward movement in Cardiology's toxicity studies. Systemic toxicity continues to have its power and influence throughout the period. It is the most chosen drug distribution method, which is also one of the crucial causes of toxic reactions. Renal and Hepatotoxicity are the major applications to witness rapid growth in the future.

ADME Toxicology Testing Market – By End-Users:

• Hospitals and clinics
• Diagnostic centers
• Pathological Labs
• Others

ADME Toxicology Testing Market – By Region:

• North America
  • The U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of EU
• Asia-Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Rest of Latin America
• Middle East
• Africa

Geographically, the global ADME toxicology testing market is looking forward to a steady pace throughout the forecast timespan. North American ADME Toxicology Testing Market is positioned first in holding the highest shares of the global market. The quick adoption of the latest technologies and maintaining strict management rules by the government are propelling the market demand in this region.

The Asia Pacific and Europe regions are to have dominant shares shortly. Changes in the policies favoring pharmaceutical companies and the growing number of research institutes help the market growth.

KEY MARKET PLAYERS:

Some of the noteworthy companies dominating the global ADME toxicology testing market profiled in this report are Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC and MultiCASE, Inc.

MAJOR HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

• On February 12, 2020, QLinea AB has announced that the company has made a partnership with Thermo Fischer scientific for the commercialization of ASTar. 
• On February 07, 2020, TFS has introduced the IonTorrent CarrierSeq ECS Kit for expanding their careers.  
• On February 14, 2020, Thermo Fisher to collaborate the NanoPin diagnostic platform for rapid and quantified results from patient blood-based infectious disease detection technology through the development of liquid chromatography-mass spectrometry (LC-MS) based workflows. 
• On January 27, 2020, TFS has launched the next generation, compressor free plate sealer at SLAS 2020.  
• On November 20, 2019, TFS launched the latest Forensic Qualified, an affordable and easy to use capillary electrophoresis platform. 
• On October 10, 2019, Arctoris announced a partnership with Molecule to tackle the ongoing crisis. Through its automated drug discovery platform, Arctoris made the researches and biotechnological entrepreneurs design and executed advanced cell-based and molecular biology.